AZN
Astrazeneca PLC
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
No implied move.
No implied move.
—
Astrazeneca PLC
186.63
+12.23 · +7.01%
post 186.35 −0.15%
Expected move
No implied move.
News
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | InvestorInvestor | $9.8B | 6.39% | 0.00% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $8.5B | 5.54% | +0.77% | |
| 3 | Capital International InvestorsCapital International Investors | $6.5B | 4.24% | +0.53% | |
| 4 | Norges BankNorges Bankindex-like | $6.3B | 4.14% | — | |
| 5 | Capital World InvestorsCapital World Investors | $5.6B | 3.68% | +6.41% | |
| 6 | FMRFMR | $5.4B | 3.54% | −2.39% | |
| 7 | Wellington Management GroupWellington | $5.4B | 3.51% | +20.15% | |
| 8 | Legal & General GroupLegal & General | $4.8B | 3.15% | −0.39% | |
| 9 | JPMorgan ChaseJPMorgan Chase | $3.7B | 2.40% | +3.30% | |
| 10 | Vanguard Asset ManagementVanguardindex-like | $3.5B | 2.28% | +0.96% | |
| 11 | Primecap ManagementPrimecap | $3.4B | 2.24% | −0.65% | |
| 12 | Bank of AmericaBank of America | $3.4B | 2.19% | −7.18% | |
| 13 | T. Rowe Price AssociatesT. Rowe Price | $3.2B | 2.06% | −14.74% | |
| 14 | AmundiAmundi | $3.1B | 2.04% | +6.74% | |
| 15 | Franklin ResourcesFranklin Resources | $3.1B | 2.03% | −7.20% | |
| 16 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.5B | 1.62% | +0.73% | |
| 17 | Deutsche Bank AG\Deutsche Bank AG\ | $2.4B | 1.57% | +4.21% | |
| 18 | Jupiter TopcoJupiter Topco | $2.2B | 1.45% | — | |
| 19 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainDZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $2.2B | 1.43% | −9.41% | |
| 20 | Fisher Asset ManagementFisher | $2.1B | 1.38% | +2.77% | |
| 21 | AvivaAviva | $2.0B | 1.33% | −1.70% | |
| 22 | Royal Bank of CanadaRoyal Bank of Canada | $2.0B | 1.29% | +0.40% | |
| 23 | InvescoInvesco | $1.9B | 1.26% | +0.73% | |
| 24 | Royal London Asset ManagementRoyal London | $1.9B | 1.26% | −1.35% | |
| 25 | Goldman Sachs GroupGoldman Sachs | $1.9B | 1.24% | −9.35% |
1,479 managers report $153.0B of Astrazeneca on form 13F for the quarter ended Jun 30 '26. 48 of them hold 80% of it; Investor is largest at 6.39%.
No thesis.